The FDA approved the first generics of dapagliflozin (Farxiga) tablets for adults with type 2 diabetes, the agency announced on Tuesday. Generics of the SGLT2 inhibitor are indicated for glycemic ...

Monday - Friday, 11:00 - 12:00 SIN/HK | 0500 - 06:00 CET In this video The patent on semaglutide, found in Novo Nordisk's Ozempic and Wegovy weight-loss drugs, expired in India on March 20. Vikrant ...

Semaglutide is part of a group of medicines called GLP-1 receptor agonists, commonly used to manage type 2 diabetes. In recent years, it has also gained worldwide attention for helping with weight ...

Over the last year, Sanofi has been busy reshaping itself to focus more on innovative drugs, including selling a controlling stake in its former consumer business and using those proceeds to strike a ...

Jeff Galloway was an Olympian. A collegiate All-American. A successful marathoner. A dedicated race director and run store owner. A lifelong runner. Created by Galloway in 1976, the run/walk method, a ...

Muriel, from the Auxiliary of Social Life, works at the home of Mr. T, who has multiple sclerosis, in Pas de Calais, France, on June 11, 2023. (Astier / BSIP via AFP) (CN) — For people living with ...

Throughout the year, Teva had momentum in innovative medicines, scaling its global generics and biosimilars portfolio. On the brand side, Teva said it continued to showcase strong performance of its ...

During an interview with The New York Times, Stewart was asked about method acting after the conversation turned to Marlon Brando’s work on “Superman: The Movie.” The legendary actor reportedly would ...

Our choice for the Method of the Year 2025 is EM-based connectomics, for the detailed insights into brain structure and function that the generated wiring diagrams enable. A large network of ...

Kristen Stewart is weighing in on the Method acting debate. “The Chronology of Water” director recently told the New York Times that acting is by nature “quite embarrassing and unmasculine,” and that ...

Cuban urges FDA fee waiver to boost US generics manufacturing Cost Plus Drugs plans to boost US production if fees are waived FDA charges $360,000 per generic drug approval application Trump promised ...